Pierre‐Marie Morice
0000-0002-9313-2701
Publication & Citation Trends
Publications
0 total
Risk of thyroid cancer related to glucagon‐like peptide‐1 receptor agonists: A systematic review with meta‐analysis of harms of randomized controlled trials
Cited by 5
Semantic Scholar
Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response
Cited by 4
Semantic Scholar
Automated scoring to assess RAD51-mediated homologous recombination in ovarian patient-derived tumor organoids.
Cited by 3
Semantic Scholar
Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO’s pharmacovigilance database OA
Cited by 5
Semantic Scholar
Arterial hypertension associated with PARPi: A meta‐analysis of 41 placebo randomized controlled trials combined with a World Health Organization's pharmacovigilance study
Cited by 2
Semantic Scholar
Pharmacokinetic validation of a new protocol of chronic oral administration of aripiprazole in male C57 Bl/6 mice through drinking solution. OA
Cited by 1
Semantic Scholar
The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers OA
Cited by 9
Semantic Scholar
Research Topics
PARP inhibition in cancer therapy
(34)
Acute Myeloid Leukemia Research
(17)
Ovarian cancer diagnosis and treatment
(11)
DNA Repair Mechanisms
(3)
Cancer-related molecular mechanisms research
(3)
Affiliations
Inserm
Institut Gustave Roussy
Sorbonne Université
Hôpital Armand-Trousseau
Normandie Université